EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels

Alejandra V Rodríguez Rondón iD, Mila S Welling, Erica L T van den Akker iD, Elisabeth F C van Rossum, Elles M J Boon, Mieke M van Haelst, Patric J D Delhanty, Jenny A Visser iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Alejandra V Rodríguez Rondón und 7 weiteren Autor:innen. Beteiligte Einrichtung: Obesity Center CGG and Expertise Center Genetic Obesity, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Receptor, Melanocortin, Type 4, alpha-MSH, Signal Transduction, Cyclic AMP. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The melanocortin-4 receptor (MC4R) plays an important role in body weight regulation. Pathogenic MC4R variants are the most common cause of monogenic obesity.

Objective

We have identified 17 MC4R variants in adult and pediatric patients with obesity. Here we aimed to functionally characterize these variants by analyzing 4 different aspects of MC4R signaling. In addition, we aimed to analyze the effect of setmelanotide, a potent MC4R agonist, on these MC4R variants. Materials and Methods Cell surface expression and α-melanocyte stimulating hormone (α-MSH)- or setmelanotide-induced cAMP response, β-arrestin-2 recruitment, and ERK activation were measured in cells expressing either wild type or variant MC4R.

Results

We found a large heterogeneity in the function of these variants. We identified variants with a loss of response for all studied MC4R signaling, variants with no cAMP accumulation or ERK activation but normal β-arrestin-2 recruitment, and variants with normal cAMP accumulation and ERK activation but decreased β-arrestin-2 recruitment, indicating disrupted desensitization and signaling mechanisms. Setmelanotide displayed a greater potency and similar efficacy as α-MSH and induced significantly increased maximal cAMP responses of several variants compared to α-MSH. Despite the heterogeneity in functional response, there was no apparent difference in the obesity phenotype in our patients.

Conclusion

We show that these obesity-associated MC4R variants affect MC4R signaling differently yet lead to a comparable clinical phenotype. Our results demonstrate the clinical importance of assessing the effect of MC4R variants on a range of molecular signaling mechanisms to determine their association with obesity, which may aid in improving personalized treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Melanocortin, Type 4alpha-MSHSignal TransductionCyclic AMPHumansObesityHEK293 CellsAdultChild

Stichwörter der Autor:innen

G-protein-coupled receptorsgenetic variationmelanocortin-4 receptorobesitysetmelanotideα-MSHβ-arrestins

Substanzen

Receptor, Melanocortin, Type 4alpha-MSHMC4R protein, humansetmelanotideCyclic AMP

Autor:innen und Institutionen

  • Obesity Center CGG and Expertise Center Genetic Obesity, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Department of Pediatrics, Division of Endocrinology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Department of Human Genetics, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands.

ORCID-Profile: Alejandra V Rodríguez Rondón, Erica L T van den Akker, Jenny A Visser

Zitieren

APA

Rodríguez Rondón, A. V., Welling, M. S., van den Akker, E. L. T., van Rossum, E. F. C., Boon, E. M. J., van Haelst, M. M., Delhanty, P. J. D., & Visser, J. A. (2024). MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae210

Vancouver

Rodríguez Rondón AV, Welling MS, van den Akker ELT, van Rossum EFC, Boon EMJ, van Haelst MM, et al. MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae210

BibTeX
@article{RodrguezRondn2024,
  author = {Rodríguez Rondón, Alejandra V and Welling, Mila S and van den Akker, Erica L T and van Rossum, Elisabeth F C and Boon, Elles M J and van Haelst, Mieke M and Delhanty, Patric J D and Visser, Jenny A},
  title = {MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae210}
}
Kostenlos starten →